.Amgen has actually shared (PDF) the first phase 3 data on its own $400 million dermatitis medicine,...
.Biogen and also UCB's gamble on improving into stage 3 astride a failed study looks to have actuall...
.Italian biotech Aptadir Therapeutics has actually introduced along with the pledge that its own pip...
.Wave Life Sciences has actually fulfilled its own goal in a Duchenne muscle dystrophy (DMD) study, ...
.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, takin...
.Achilles Rehabs has shreded its own approach. The British biotech is actually quiting working on it...
.Aligos Therapeutics is actually declaring a midstage gain in metabolic-dysfunction connected steato...
.Basilea Pharmaceutica's job building brand-new antifungals has actually gotten a substantial increa...
.Having presently scooped up the U.S. rights to Capricor Therapeutics' late-stage Duchenne muscular ...
.After pushing back the decision date for Applied Rehabs' metabolic problem medication govorestat, t...